Posts Tagged ‘biopharmaceuticals’

« Older Entries
Newer Entries »

ARNA stronger, HBAN volume leader, RXII tumbles

Monday, December 20th, 2010

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) pushed upward 23.64 percent in price Monday to $2.04. Volume of 14,985,720 shares nearly doubled its full-day average. The San Diego-based ARNA is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors.

Huntington Bancshares Inc. (Nasdaq: HBAN) traded in 27,626,739 shares, bested its daily average by a half. Share prices for HBAN moved moderately ahead 4.98 percent to $6.54. Columbus-based HBAN is a $53-billion regional bank holding company

RXi Pharmaceuticals Corp. (Nasdaq: RXII) stumbled in price 11.43 percent Monday to $2.79, on volume of 705,157 shares, nearly quadrupled its full-day average. RXII is a recognized leader in RNAi-based therapeutic discovery and development

Tags: , , , , , , ,
Posted in Financial Stocks, Health Care Stocks | No Comments »

CYPB spreads wings, C solid, MOTR in reverse

Wednesday, December 15th, 2010

Cypress Bioscience (NasdaqGM: CYPB) jumped 12.2% to$6.45, on volume of 8,570,704, or 16 times its full-day average, after it agreed to be acquired by Ramius LLC and Royalty Pharma for about $255 million in cash, ending a takeover battle that began in July.

Citigroup (NYSE: C) traded in 155,455,525 shares, making good headway on its daily average of 539,270,000 shares. Share prices retreated 0.53 per cent, however, Wednesday, to $4.66.

Motricity Inc. (NasdaqGM: MOTR) backtracked 13.53 percent in Wednesday morning trading at $18.40. Volume of 3,277,545 shares tramped its full-day average of 559,200. MOTR, based in Bellevue, Wash., is a leading mobile data solutions provider exclusively focused on the rapidly growing mobile Internet market.

Tags: , , , , , , , ,
Posted in Financial Stocks, pharmaceutical stocks, Technology Stocks | No Comments »

CRDC in gear, INTC busy trader, ENMD drops

Monday, December 13th, 2010

Cardica Inc. (NasdaqGM: CRDC) rocketed up 23.49 percent mid-afternoon Monday to $3.47. Volume for the stock was 630,521 shares, or more than 10 times its normal daily average. CRDC designs and manufactures proprietary stapling and anastomotic devices for cardiac and endoscopic surgical procedures.

Intel Corp. (NasdaqGS: INTC) traded in 56,971,125 shares, closing in on Intel’s its normal daily average of 59,805,000. Prices for the chipmaker tailed off a bit, though, 1.87 percent to $21.50.

EntreMed Inc. (NasdaqCM: ENMD) moved earthward 7.35 percent to $5.04 on Monday afternoon. Volume was 206,151 shares, more than double its full-day average. ENMD, based in Rockville, Md., is a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer

Tags: , , , , , , ,
Posted in Health Care Stocks, pharmaceutical stocks, Technology Stocks | No Comments »

AIG jumps, F rolls off the lot, TNGN stumbles

Thursday, December 9th, 2010

American International Group, Inc. (NYSE: AIG) hiked in price Thursday by 13.03 percent to $47.72. Volume in the stock was 20,815,012, or better than five times normal volume.

Ford motor Company (NYSE: F) traded in 37,567,113 shares Thursday, but considerably less than half its daily average of 84,616,400. Share prices were flat at $16.78. The car maker Thursday boasted that its 2011 Ford Explorer V6 fuel economy ratings are now EPA-approved at 17 mpg city and 25 mpg highway, a 25-percent improvement over the previous V6 model

Tengion Inc. (NasdaqGM: TNGN) took a hit in price 12.31 percent Thursday to $2.28, on volume of 48,517 shares, more than four times its normal full-day average. The Pennsylvania-based TNGN is a leader in regenerative medicine.

Tags: , , , , , ,
Posted in Consumer Discretionary Stocks, Financial Stocks, pharmaceutical stocks | No Comments »

MCP marches, PFE trades widely, MCOX falls

Monday, December 6th, 2010

Molycorp. Inc (NYSE: MCP) was a winner Monday, muscling up 18.06 percent in price to $32.82. Volume of 7,226,528 shares was near triple MCP’s normal full-day average volume. Colorado-based Molycorp, Inc. is the only rare earth oxide (REO) producer in the Western hemisphere and currently produces approximately 3,000 tons of commercial rare earth materials per year.

Pfizer Inc. (NYSE: PFE) traded in 45,357,434shares, making it a leader in volume, edging its daily average of 42,923,900. Shares in PFE inched up 0.42 percent to close Monday at $16.83. PFE announced today that a significantly higher proportion of patients with newly diagnosed chronic myeloid leukemia who were treated with bosutinib (39% ) experienced a major molecular response (MMR), a secondary endpoint, compared with patients treated with imatinib (26% ) in the intent-to-treat population

Mecox Lane Ltd. (NasdaqGM: MCOX) faded in price 11.54 percent Monday afternoon to wind up at $6.90, on volume of 1,491,840 shares, slightly above its daily volume average. MCOX operates China’s leading online platform for apparel and accessories as measured by revenues in 2009.

Tags: , , , , , , , , ,
Posted in Consumer Discretionary Stocks, Energy Stocks, pharmaceutical stocks | No Comments »

« Older Entries
Newer Entries »